• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥沙利铂化疗期间发生的隐源性机化性肺炎:病例报告

Cryptogenic organizing pneumonitis during oxaliplatin chemotherapy for colorectal cancer: case report.

作者信息

Garrido Marcelo, O'Brien Andrés, González Sergio, Clavero José Miguel, Orellana Eric

机构信息

Departamentos de Hematología-Oncología, Centro de Cáncer, Pontificia Universidad Católica de Chile, Santiago, Chile.

出版信息

Chest. 2007 Dec;132(6):1997-9. doi: 10.1378/chest.07-0536.

DOI:10.1378/chest.07-0536
PMID:18079234
Abstract

The patient presented here is a 30-year-old woman who underwent anterior resection for the initial treatment of rectal cancer. A postoperative study showed a single liver metastasis. The patient received adjuvant pelvic radiotherapy with concomitant 5-fluorouracil (5-FU) treatment followed by liver metastasectomy 6 weeks after the completion of radiation therapy and chemotherapy. Adjuvant therapy with 5-FU, leucovorin, and oxaliplatin (FOLFOX 4 regimen) was continued. The initial five cycles were well tolerated with the occurrence of only paresthesia that did not interfere with function. After the sixth cycle of the treatment, progressive dyspnea and persistent cough developed in the patient, although her clinical history was negative for lung disease. A chest radiograph revealed diffuse bilateral interstitial infiltrates, and a chest CT scan showed bilateral alveolar infiltrates predominant in the right lung. Lung biopsy by video-assisted thoracoscopy was performed, and the histologic report showed cryptogenic organizing pneumonitis (COP). Prednisone therapy (1 mg/kg/d) resulted in a very good clinical response. In fact, the patient had complete remission of respiratory symptoms including cough and dyspnea after 4 days of treatment, and the chest CT scan showed complete resolution of lung infiltrates after 4 weeks. One month later, the patient continued adjuvant treatment with six cycles of 5-FU, leucovorin, and irinotecan (ie, the FOLFIRI regimen) without complications. Thus, oxiplatin was implicated as the likely cause of this drug-induced lung toxicity, which is a very rare complication associated with platins. Diffuse interstitial lung disease, particularly COP, has been described following the administration of the cytotoxic agents bleomycin and busulfan, but a connection to oxaliplatin has not been reported before this case.

摘要

本文介绍的患者是一名30岁女性,因直肠癌接受了初次手术,行前切除术。术后检查发现单发肝转移。患者接受了盆腔辅助放疗,并同时使用5-氟尿嘧啶(5-FU)治疗,放疗和化疗结束6周后进行了肝转移灶切除术。继续使用5-FU、亚叶酸钙和奥沙利铂进行辅助治疗(FOLFOX 4方案)。最初的五个周期耐受性良好,仅出现未影响功能的感觉异常。在第六个周期治疗后,患者出现进行性呼吸困难和持续性咳嗽,尽管其肺部疾病临床病史为阴性。胸部X线片显示双侧弥漫性间质浸润,胸部CT扫描显示双侧肺泡浸润,以右肺为主。通过电视辅助胸腔镜进行了肺活检,组织学报告显示为隐源性机化性肺炎(COP)。泼尼松治疗(1mg/kg/d)产生了非常好的临床反应。事实上,患者在治疗4天后咳嗽和呼吸困难等呼吸道症状完全缓解,胸部CT扫描显示4周后肺部浸润完全消退。1个月后,患者继续接受六个周期的5-FU、亚叶酸钙和伊立替康辅助治疗(即FOLFIRI方案),未出现并发症。因此,奥沙利铂被认为是这种药物性肺毒性的可能原因,这是一种与铂类药物相关的非常罕见的并发症。在使用细胞毒性药物博来霉素和白消安后曾有弥漫性间质性肺病,特别是COP的报道,但在此病例之前尚未有与奥沙利铂相关的报道。

相似文献

1
Cryptogenic organizing pneumonitis during oxaliplatin chemotherapy for colorectal cancer: case report.奥沙利铂化疗期间发生的隐源性机化性肺炎:病例报告
Chest. 2007 Dec;132(6):1997-9. doi: 10.1378/chest.07-0536.
2
Cryptogenic organizing pneumonia during adjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and leucovorin (FOLFOX) for colon cancer.结肠癌患者在接受奥沙利铂、5-氟尿嘧啶和亚叶酸钙(FOLFOX)辅助化疗期间发生的隐源性机化性肺炎。
J Pharm Pract. 2013 Feb;26(1):62-6. doi: 10.1177/0897190012451929. Epub 2012 Jul 25.
3
[A case of interstitial lung diseases in patient treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX)].[1例接受奥沙利铂、5-氟尿嘧啶和亚叶酸钙(FOLFOX)治疗的患者发生间质性肺疾病]
Gan To Kagaku Ryoho. 2011 Feb;38(2):317-20.
4
[Efficacy and safety of bevacizumab (BEV) plus chemotherapeutic agents in the treatment of metastatic colorectal cancer, mCRC].贝伐单抗(BEV)联合化疗药物治疗转移性结直肠癌(mCRC)的疗效与安全性
Zhonghua Zhong Liu Za Zhi. 2013 Aug;35(8):604-7.
5
[Two cases of interstitial lung diseases in patients treated with oxaliplatin, 5-fluorouracil and Leucovorin (FOLFOX)].两例接受奥沙利铂、5-氟尿嘧啶和亚叶酸钙(FOLFOX)治疗的患者出现间质性肺疾病
Gan To Kagaku Ryoho. 2009 Feb;36(2):295-8.
6
[A case of metastatic lung and liver tumors from rectal cancer treated with oral UFT and CPT-11 by hepatic arterial infusion followed by FOLFOX and FOLFIRI].[1例直肠癌肺和肝转移瘤经口服优福定和伊立替康肝动脉灌注治疗后序贯FOLFOX和FOLFIRI方案的病例]
Gan To Kagaku Ryoho. 2008 Nov;35(11):1965-7.
7
[Obliterative bronchiolitis with organising pneumonia following FOLFOX 4 chemotherapy].FOLFOX 4化疗后伴机化性肺炎的闭塞性细支气管炎
Rev Mal Respir. 2010;27(1):84-7. doi: 10.1016/j.rmr.2009.06.001. Epub 2009 Dec 16.
8
Oxaliplatin, folinic acid and 5-fluorouracil (FOLFOX-4) combination chemotherapy as second-line treatment in advanced colorectal cancer patients with irinotecan failure: a Korean single-center experience.奥沙利铂、亚叶酸钙和5-氟尿嘧啶(FOLFOX-4)联合化疗作为伊立替康治疗失败的晚期结直肠癌患者的二线治疗:韩国单中心经验
Jpn J Clin Oncol. 2005 Sep;35(9):531-5. doi: 10.1093/jjco/hyi140. Epub 2005 Jul 18.
9
Interstitial lung disease following FOLFOX + FOLFIRI and bevacizumab therapy associated with leucovorin: A case report.FOLFOX + FOLFIRI与亚叶酸钙联合贝伐单抗治疗后发生的间质性肺疾病:一例报告
J Oncol Pharm Pract. 2018 Oct;24(7):540-543. doi: 10.1177/1078155217718616. Epub 2017 Jul 11.
10
Chemotherapy Alone for Patients With Stage II/III Rectal Cancer Undergoing Radical Surgery.Ⅱ/Ⅲ期直肠癌根治性手术患者单纯化疗
Oncologist. 2015 Jul;20(7):752-7. doi: 10.1634/theoncologist.2015-0038. Epub 2015 Jun 3.

引用本文的文献

1
Oxaliplatin-Induced Pulmonary Fibrosis: A Rare but Fatal Reality.奥沙利铂诱导的肺纤维化:一种罕见但致命的现实。
Cureus. 2023 Dec 31;15(12):e51411. doi: 10.7759/cureus.51411. eCollection 2023 Dec.
2
Systematic Review of Systemic Corticosteroids for Treatment of Organizing Pneumonia.系统性皮质类固醇治疗机化性肺炎的系统评价
Open Respir Arch. 2022 Sep 19;4(4):100211. doi: 10.1016/j.opresp.2022.100211. eCollection 2022 Oct-Dec.
3
Acute respiratory distress syndrome (ARDS) after pressurized intraperitoneal aerosol chemotherapy with oxaliplatin: a case report.
奥沙利铂腹腔内加压雾化化疗后发生急性呼吸窘迫综合征(ARDS):一例报告
Pleura Peritoneum. 2021 Oct 5;6(4):167-170. doi: 10.1515/pp-2021-0126. eCollection 2021 Dec.
4
Oxaliplatin-related interstitial pneumonia with high-grade fever and relative bradycardia as the presenting signs: a case report.以高热和相对心动过缓为首发症状的奥沙利铂相关性间质性肺炎:一例报告
J Med Case Rep. 2021 Apr 8;15(1):153. doi: 10.1186/s13256-021-02769-7.
5
Pulmonary Fibrosis Secondary to Oxaliplatin Treatment: From Rarity to Reality: A Case Study and Literature Review.奥沙利铂治疗继发的肺纤维化:从罕见病例到临床实际:一项病例研究及文献综述
Oncol Ther. 2020 Dec;8(2):183-190. doi: 10.1007/s40487-020-00127-z. Epub 2020 Sep 3.
6
Oxaliplatin-induced bronchiolitis obliterans organizing pneumonia following hyperthermic intraperitoneal chemotherapy.高温腹腔化疗后奥沙利铂诱发的闭塞性细支气管炎并机化性肺炎
J Gastrointest Oncol. 2018 Jun;9(3):E15-E18. doi: 10.21037/jgo.2018.01.01.
7
A case report of acute pulmonary hypertension after hyperthermic intraperitoneal chemotherapy (HIPEC) and review of the literature.热灌注化疗(HIPEC)后急性肺动脉高压一例报告并文献复习
Ann Med Surg (Lond). 2018 Jan 31;27:26-31. doi: 10.1016/j.amsu.2018.01.007. eCollection 2018 Mar.
8
Prognosis and treatment of FOLFOX therapy related interstitial pneumonia: a plea for multimodal immune modulating therapy in the respiratory insufficient patient.FOLFOX治疗相关间质性肺炎的预后与治疗:呼吁对呼吸功能不全患者采用多模式免疫调节治疗
BMC Cancer. 2017 Aug 29;17(1):586. doi: 10.1186/s12885-017-3576-y.
9
Fatal interstitial pneumonia associated with oxaliplatin-based therapy in a patient with metastatic rectal cancer.一名转移性直肠癌患者接受基于奥沙利铂的治疗后发生致命性间质性肺炎。
Clin J Gastroenterol. 2011 Jun;4(3):157-161. doi: 10.1007/s12328-011-0217-x. Epub 2011 Mar 24.
10
Oxaliplatin-Induced Pulmonary Toxicity in Gastrointestinal Malignancies: Two Case Reports and Review of the Literature.奥沙利铂诱发的胃肠道恶性肿瘤肺毒性:两例报告及文献综述
Case Rep Oncol Med. 2015;2015:341064. doi: 10.1155/2015/341064. Epub 2015 May 10.